Perseus Proteomics (TSE:4882) ROE % Adjusted to Book Value : -13.57% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics ROE % Adjusted to Book Value?

Perseus Proteomics's ROE % for the quarter that ended in Dec. 2023 was -63.78%. Perseus Proteomics's PB Ratio for the quarter that ended in Dec. 2023 was 4.70. Perseus Proteomics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -13.57%.

Perseus Proteomics ROE % Adjusted to Book Value Historical Data

The historical data trend for Perseus Proteomics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics ROE % Adjusted to Book Value Chart

Perseus Proteomics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-18.25

-19.43

Perseus Proteomics Quarterly Data
	Mar18	Mar19	Dec19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial												-20.89	-24.60	-45.88	-14.62	-13.57

Competitive Comparison of Perseus Proteomics's ROE % Adjusted to Book Value

For the Drug Manufacturers - General subindustry, Perseus Proteomics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Perseus Proteomics's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perseus Proteomics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Perseus Proteomics's ROE % Adjusted to Book Value falls into.

Perseus Proteomics ROE % Adjusted to Book Value Calculation

Perseus Proteomics's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-28.37%	/	1.46
	=	-19.43%

Perseus Proteomics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-63.78%	/	4.70
	=	-13.57%

Perseus Proteomics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Perseus Proteomics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Perseus Proteomics (TSE:4882) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041

Website

https://www.ppmx.com

Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics (TSE:4882) Headlines

No Headlines